1. NIMG-34. MULTI-PARAMETRIC MR-PET IMAGING PREDICTS PHARMACOKINETICS AND CLINICAL RESPONSE TO GDC-0084 IN HUMAN RECURRENT HIGH-GRADE GLIOMA. (11th November 2019) Authors: Ellingson, Benjamin; Yao, Jingwen; Raymond, Catalina; Nathanson, David; Simpson, Jeremy; Garner, James; Olivero, Alan; Mueller, Lars; Rodon, Jordi; Gerstner, Elizabeth; Cloughesy, Timothy; Wen, Patrick Journal: Neuro-oncology Issue: Volume 21(2019)Supplement 6 Page Start: vi168 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. ACTR-51. PHASE 2 STUDY TO EVALUATE THE SAFETY, PHARMACOKINETICS AND CLINICAL ACTIVITY OF PI3K/MTOR INHIBITOR GDC-0084 GIVEN TO GLIOBLASTOMA (GBM) PATIENTS WITH UNMETHYLATED O6-METHYLGUANINE-METHYLTRANSFERASE PROMOTER STATUS. (5th November 2018) Authors: Wen, Patrick; Cloughesy, Timothy; de Groot, John; Battiste, James; Garner, James; Simpson, Jeremy; Olivero, Alan; Gerstner, Elizabeth Journal: Neuro-oncology Issue: Volume 20(2018)Supplement 6 Page Start: vi23 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. ACTR-64. PHASE 2 STUDY TO EVALUATE THE SAFETY, PHARMACOKINETICS AND CLINICAL ACTIVITY OF PI3K/mTOR INHIBITOR GDC-0084 IN GBM PATIENTS WITH UNMETHYLATED O6-METHYLGUANINE-METHYLTRANSFERASE (MGMT) PROMOTER STATUS. (11th November 2019) Authors: Wen, Patrick; DeGroot, John; Battiste, James; Goldlust, Samuel; Garner, James; Simpson, Jeremy; Kijlstra, Jelle; Olivero, Alan; Cloughesy, Timothy Journal: Neuro-oncology Issue: Volume 21(2019)Supplement 6 Page Start: vi28 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. CTNI-44. INTERIM RESULTS OF PHASE 2 STUDY TO EVALUATE PI3K/mTOR INHIBITOR PAXALISIB (GDC-0084) GIVEN TO NEWLY DIAGNOSED GLIOBLASTOMA PATIENTS WITH UNMETHYLATED O6-METHYLGUANINE-METHYLTRANSFERASE PROMOTER. (9th November 2020) Authors: Wen, Patrick; de Groot, John; Battiste, James; Goldlust, Samuel; Damek, Denise; Garner, James; Simpson, Jeremy; Olivero, Alan; Cloughesy, Timothy Journal: Neuro-oncology Issue: Volume 22(2020)Supplement 2 Page Start: ii52 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. CTNI-27. MULTI-CENTER, PHASE 2 STUDY EVALUATING THE PHARMACOKINETICS, SAFETY AND PRELIMINARY EFFICACY OF PAXALISIB IN NEWLY DIAGNOSED ADULT PATIENTS WITH UNMETHYLATED GLIOBLASTOMA (GBM). (14th November 2022) Authors: Wen, Patrick Y; de Groot, John; Battiste, James; Goldlust, Samuel; Damek, Denise; Ellingson, Benjamin; Garner, James; Friend, John; Simpson, Jeremy; Olivero, Alan; Cloughesy, Timothy Journal: Neuro-oncology Issue: Volume 24(2022)Supplement 7 Page Start: vii76 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. MMAP-05 PHASE I STUDY OF CONCURRENT PAXALISIB AND RADIATION THERAPY IN PATIENTS WITH SOLID TUMOR BRAIN METASTASES OR LEPTOMENINGEAL METASTASES HARBORING PI3K PATHWAY MUTATIONS: RESULTS FROM THE DOSE-ESCALATION COHORT. (5th August 2022) Authors: Yang, Jonathan; Mann, Justin; Pike, Luke; Zinovoy, Melissa; Young, Robert; Offin, Michael; Mitchell, Ryan; Kazarian, Arousiak; Shadat, Tamim; Garner, James; Simpson, Jeremy; Friend, John; Gavrilovic, Igor; Piotrowski, Anna; Wilcox, Jessica; Malani, Rachna; Diamond, Eli Journal: Neuro-oncology advances Issue: Volume 4(2022)Supplement 1 Page Start: i15 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Implementation of the Rank-Weighted Co-localization (RWC) algorithm in multiple image analysis platforms for quantitative analysis of microscopy images. Issue 1 (December 2016) Authors: Singan, Vasanth; Simpson, Jeremy Journal: Source code for biology and medicine Issue: Volume 11:Issue 1(2016) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗